Pseudoporphyria: discussion of etiologic agents
Pseudoporphyria, a rare photodistributed blistering skin condition, may be underreported. This case highlights a patient with typical symptoms but negative porphyrin tests, suggesting more frequent occurrence than previously believed.
Area of Science:
- Dermatology
- Photomedicine
- Histopathology
Background:
- Pseudoporphyria is a rare photodistributed bullous disorder characterized by normal porphyrin levels.
- The condition is considered extremely rare, with fewer than 100 cases reported historically.
- This rarity suggests potential underreporting in clinical practice.
Observation:
- A case of pseudoporphyria is presented in a patient with nonpruritic, nonpainful blisters on the dorsal hands.
- The patient's clinical presentation was consistent with photodistributed blistering.
- Diagnostic evaluations, including urinary porphyrin studies, were negative.
Findings:
- Histopathological examination of the skin biopsy revealed a split at the dermal-epidermal junction.
- Comprehensive laboratory tests, including serum and fecal porphyrin evaluations, were negative.
- The absence of elevated porphyrins differentiates pseudoporphyria from other porphyrias.
Implications:
- The findings suggest that pseudoporphyria may be more common than previously recognized.
- Increased clinical awareness is needed to identify and report cases of pseudoporphyria.
- Accurate diagnosis is crucial to distinguish pseudoporphyria from other blistering disorders and avoid unnecessary investigations for porphyria.
More Related Videos
11:00Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress
Published on: August 31, 2015
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Related Concept Videos
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Drug toxicity: Idiosyncratic Reactions
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Chronic Pancreatitis II: Pathophysiology
